(Total Views: 431)
Posted On: 09/04/2025 8:50:51 AM
Post# of 156693
CytoDyn Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Download as PDFSeptember 04, 2025 8:30am EDT
VANCOUVER, Washington, Sept. 04, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"
, a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, today announced a change of time for management’s live presentation at the H.C. Wainwright 27th Annual Global Investment Conference, to Wednesday, September 10, at 9 a.m. EDT.
CytoDyn CFO, Robert E. Hoffman, will deliver a live company presentation and will be available for one-on-one meetings throughout the event, which is taking place September 8-10, 2025, in New York City.
Details of the presentation are now as follows:
Event: H.C. Wainwright 27th Annual Global Investment Conference
Date: September 10, 2025
Time: 9 a.m. EDT
Webcast: register here
https://www.cytodyn.com/newsroom/press-releas...wainwright
Download as PDFSeptember 04, 2025 8:30am EDT
VANCOUVER, Washington, Sept. 04, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"
, a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, today announced a change of time for management’s live presentation at the H.C. Wainwright 27th Annual Global Investment Conference, to Wednesday, September 10, at 9 a.m. EDT. CytoDyn CFO, Robert E. Hoffman, will deliver a live company presentation and will be available for one-on-one meetings throughout the event, which is taking place September 8-10, 2025, in New York City.
Details of the presentation are now as follows:
Event: H.C. Wainwright 27th Annual Global Investment Conference
Date: September 10, 2025
Time: 9 a.m. EDT
Webcast: register here
https://www.cytodyn.com/newsroom/press-releas...wainwright
(3)
(0)
